Abiopharma

(99% Neutral) Aclarion, Inc. (ACONW) Announces Business Combination

ENvue Medical Launches Program to Address Patient Pain and Discomfort with Indwelling Nasogastric Tubes Based on Previously Published, Peer-Reviewed Clinical Research

New Form 424B5 - Aclarion, Inc. Filed: 2026-01-09 AccNo: 0001683168-26-000166 Size: 427 KB

New Form SCHEDULE 13G/A - Aclaris Therapeutics, Inc. Filed: 2026-01-09 AccNo: 0000929638-26-000098 Size: 14 KB

Integer Holdings Corporation Sued for Securities Law Violations - Contact Levi & Korsinsky Before February 9, 2026 to Discuss Your Rights - ITGR

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of March 2, 2026 in agilon health, inc. Lawsuit - AGL

Lost Money on Perrigo Company plc(PRGO)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky

Akari Therapeutics Releases New CEO Corner Segment Highlighting 2025 Progress and Path to Clinical Transition In 2026

Oncolytics Biotech® Outlines Strategic Rationale for Proposal to Change Jurisdiction of Incorporation to Nevada

Senti Bio to Participate in Panel Presentation at Biotech Showcase Alongside the J.P. Morgan Annual Healthcare Conference

(85% Positive) PDS BIOTECHNOLOGY CORPORATION (PDSB) Announces Enrollment Update for basis Due to Patient Enrollment Issues, Regulatory Process, Safety Review

Autonomix Showcases Compelling PoC Study Clinical Data Showing Rapid and Durable Pain Relief Across All Disease Stages of Pancreatic Cancer at the 2026 ASCO Gastrointestinal (GI) Cancers Symposium

PDS Biotech Announces FDA Alignment on use of Progression Free Survival (PFS) as Primary Endpoint

(94% Positive) EVOLUS, INC. (EOLS) Reports Q1 2026 Financial Results

New Form 424B5 - GRI Bio, Inc. Filed: 2026-01-09 AccNo: 0001824293-26-000005 Size: 8 KB